Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Brain Neoplasms 2Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Cyclophosphamide 8Mycophenolic Acid 6Whole-Body Irradiation 5Busulfan 5fludarabine phosphate 4fludarabine 4Tacrolimus 4Cyclosporine 4Rituximab 3Etoposide 3Cytarabine 3venetoclax 2ruxolitinib 2pegfilgrastim 2blinatumomab 2asciminib 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Inotuzumab Ozogamicin 2Filgrastim 2tocilizumab 1ricolinostat 1rasburicase 1pembrolizumab 1pegylated granulocyte colony-stimulating factor, human 1nilotinib 1idelalisib 1ibrutinib 1ceralasertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Mental Status and Dementia Tests × 30 days × Clear all
NCT05011045 2026-05-20

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

M.D. Anderson Cancer Center

Recruiting
100 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡